View Future GrowthPorvair 과거 순이익 실적과거 기준 점검 5/6Porvair은 연평균 10.3%의 비율로 수입이 증가해 온 반면, Machinery 산업은 수입이 8.5% 증가했습니다. 매출은 연평균 7.1%의 비율로 증가했습니다. Porvair의 자기자본이익률은 10.7%이고 순이익률은 9.2%입니다.핵심 정보10.25%순이익 성장률10.15%주당순이익(EPS) 성장률Machinery 산업 성장률8.77%매출 성장률7.06%자기자본이익률10.73%순이익률9.23%다음 순이익 업데이트08 Feb 2027최근 과거 실적 업데이트공고 • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027공고 • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026공고 • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026공고 • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025공고 • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025공고 • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024모든 업데이트 보기Recent updates공고 • Jun 29Porvair plc Declares Interim Dividend, Payable on August 21, 2026The Directors of Porvair plc have declared an interim dividend of 2.4 pence (H1 2025: 2.2 pence) per share to be paid on 21 August 2026 to shareholders on the register at the close of business on 17 July 2026; the ex-dividend date is 16 July 2026.공고 • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027공고 • May 20Richard Bernstein Calls for Sale of PorvairOn May 19, 2026, Richard Bernstein, founder and former investment manager of Crystal Amber, announced that he is reportedly calling for a sale of Porvair plc. Richard Bernstein stated that he has written to the Company’s chairman John Nicholas urging him to explore strategic alternatives for the Company. Richard Bernstein said that the Company was an attractive business currently valued by the stock market at substantially below its strategic value.공고 • Apr 16Porvair plc Approves Final DividendPorvair plc at its AGM held on April 14, 2026, approved final dividend of 4.5 pence per ordinary share.공고 • Feb 11Porvair plc Recommends Final Dividend, Payable on 8 June 2026The Directors of Porvair plc recommend the payment of a final dividend of 4.5 pence per share (2024: 4.2 pence per share) to be paid on 8 June 2026 to shareholders on the register on 1 May 2026; the ex-dividend date is 30 April 2026. This makes a total dividend for the year of6.7pence per share (2024: 6.3 pence per share).공고 • Feb 10Porvair plc, Annual General Meeting, Apr 14, 2026Porvair plc, Annual General Meeting, Apr 14, 2026. Location: the offices of burson buchanan, rose court, 2 southwark bridge road, se1 9hs, london United Kingdom공고 • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026공고 • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.공고 • Sep 27Porvair plc Announces Board ChangesPorvair plc announced that Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025. Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI). Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland. On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair. Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025. Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.공고 • Jun 30Porvair plc Declares an Interim Dividend, Payable on 22 August 2025The Directors of Porvair plc have declared an interim dividend of 2.2 pence (2024: 2.1 pence) per share to be paid on 22 August 2025 to shareholders on the register at the close of business on 18 July 2025; the ex-dividend date is 17 July 2025.공고 • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026공고 • Apr 17Porvair plc Announces Change of Remuneration Committee Chair, Effective April 15, 2025Porvair plc announced that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025. Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement. Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment. Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee.공고 • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025공고 • Oct 28Porvair plc Announces Appointment of Sheena Mackay as an Independent Non-Executive Director and Joins Its Audit Committee, Remuneration Committee and Nomination CommitteePorvair plc announced the appointment of Sheena Mackay as an Independent Non-Executive Director of the Company with effect from 28 October 2024. Sheena is a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. Sheena was a Non-Executive Director at Foxtons Group plc, the London based estate agency, from 2017 to 2023. Sheena's executive career spans more than 30 years in human capital management. Sheena was Group Human Resources Director for Smiths Group plc, a FTSE 100 global industrial technology company, between 2016 and 2022. Prior to Smiths, Sheena was Group Human Resources Director at Aggreko plc, a global supplier of temporary power and temperature control equipment, BBA Aviation plc, a multinational aviation services company, and SSL International Group plc, a multinational manufacturer and supplier of healthcare products. Prior to SSL Sheena's early career was at the General Electric Company plc, a global FTSE 100 industrial conglomerate. On appointment, Sheena will join the Audit Committee, Remuneration Committee and Nomination Committee.공고 • Sep 23+ 2 more updatesPorvair plc Announces Chief Executive Officer ChangesPorvair plc announce the appointment of Hooman Caman Javvi as Chief Executive Officer designate and Director of the Company. He is expected to join the Group on 6 January 2025 and assume the role of Chief Executive on the retirement of Ben Stocks following the Company's AGM on 15 April 2025. Hooman was, until recently, Group Chief Operating Officer and member of the Board of Hill & Smith plc, a FTSE 250 international provider of sustainable infrastructure products and services. Before joining Hill & Smith in 2022, Hooman spent 11 years in senior management roles at Hitachi Energy and the ABB Group. He has an Engineering and Management degree from Linkoping University in Sweden and an MBA from the Stockholm School of Economics.공고 • Jul 01Porvair plc Declares Interim Dividend, Payable on 21 August 2024The Directors of Porvair plc have declared an interim dividend of 2.1 pence (2023: 2.0 pence) per share to be paid on 21 August 2024 to shareholders on the register at the close of business on 19 July 2024; the ex-dividend date is 18 July 2024.공고 • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025공고 • Apr 03Porvair plc Announces Resignation of Sarah Vawda as DirectorPorvair plc announces that Sarah Vawda resigned from the Board with immediate effect. a consequence of Sarah's resignation, AGM Resolution 10 "To elect Sarah Vawda as a Director" will be withdrawn from the resolutions to be put to the Company's AGM on 16 April 2024.공고 • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024공고 • Sep 07Porvair plc, Annual General Meeting, Apr 16, 2024Porvair plc, Annual General Meeting, Apr 16, 2024.공고 • Jul 04Porvair plc Declares an Interim Dividend, Payable on 23 August 2023Porvair plc announced the Directors have declared an interim dividend of 2.0 pence (2022: 1.9 pence) per share to be paid on 23 August 2023 to shareholders on the register at the close of business on 21 July 2023; the ex-dividend date is 20 July 2023.공고 • Jun 27Porvair plc Announces Appointment of Sarah Vawda as an Independent Non-Executive Director of the CompanyPorvair plc announced the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023. Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listedreputation management, marketing and communications,software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees ofNoveltech Private Feeds Ltd. (India),a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire. Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC. On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.공고 • Jun 24Porvair plc to Report Fiscal Year 2023 Results on Jan 29, 2024Porvair plc announced that they will report fiscal year 2023 results on Jan 29, 2024공고 • May 06Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc.Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc. on March 3, 2023.Porvair plc (LSE:PRV) completed the acquisition of Business and Assets of HRW Inc. on March 3, 2023.공고 • May 05Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft.Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft. on May 4, 2023. Regulatory approval is expected to take around three months. Ratiolab has annual external revenues of around €12 million. Sally Sha, Ralf Hoffman, Jürgen Wohlfart and John Kim of EC Mergers & Acquisitions acted as exclusive financial advisor to Ratiolab.공고 • Jan 31Porvair plc to Report First Half, 2023 Results on Jul 03, 2023Porvair plc announced that they will report first half, 2023 results on Jul 03, 2023매출 및 비용 세부 내역Porvair가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이OTCPK:PVAR.F 매출, 비용 및 순이익 (GBP Millions)날짜매출순이익일반관리비연구개발비31 May 262021944028 Feb 261981844030 Nov 251941844031 Aug 251951844031 May 251961743028 Feb 251941743030 Nov 241931643031 Aug 241861642031 May 241801541029 Feb 241781641030 Nov 231761641031 Aug 231781640031 May 231811639028 Feb 231771539030 Nov 221731539031 Aug 221661335031 May 221591231028 Feb 221531231030 Nov 211461231031 Aug 211391131031 May 211311031028 Feb 21133931030 Nov 20135831031 Aug 201411032031 May 201461133029 Feb 201461133030 Nov 191451133031 Aug 191431132031 May 191411132028 Feb 191351032030 Nov 181291032031 Aug 181251029031 May 181211026028 Feb 18118926030 Nov 17116926031 Aug 17115826031 May 17113826028 Feb 17111826030 Nov 16109826031 Aug 16105724031 May 16102723029 Feb 1699723030 Nov 1596723031 Aug 15987220양질의 수익: PVAR.F는 고품질 수익을 보유하고 있습니다.이익 마진 증가: PVAR.F의 현재 순 이익률 (9.2%)은 지난해 (8.7%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PVAR.F의 수익은 지난 5년 동안 연평균 10.3% 증가했습니다.성장 가속화: 지난 1년간 PVAR.F 의 수익 증가율(10.3%)은 연간 평균(10.3%)을 초과합니다.수익 대 산업: PVAR.F의 지난 1년 수익 증가율(10.3%)은 Machinery 업계의 5.5%를 상회했습니다.자기자본이익률높은 ROE: PVAR.F의 자본 수익률(10.7%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YCapital-goods 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/11 05:09종가2026/07/16 00:00수익2026/05/31연간 수익2025/11/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Porvair plc는 9명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관James BaylissBerenbergAndrew SimmsBerenbergEleanor SpencerBerenberg6명의 분석가 더 보기
공고 • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027
공고 • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026
공고 • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026
공고 • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025
공고 • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025
공고 • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024
공고 • Jun 29Porvair plc Declares Interim Dividend, Payable on August 21, 2026The Directors of Porvair plc have declared an interim dividend of 2.4 pence (H1 2025: 2.2 pence) per share to be paid on 21 August 2026 to shareholders on the register at the close of business on 17 July 2026; the ex-dividend date is 16 July 2026.
공고 • Jun 12Porvair plc to Report Fiscal Year 2026 Results on Feb 08, 2027Porvair plc announced that they will report fiscal year 2026 results on Feb 08, 2027
공고 • May 20Richard Bernstein Calls for Sale of PorvairOn May 19, 2026, Richard Bernstein, founder and former investment manager of Crystal Amber, announced that he is reportedly calling for a sale of Porvair plc. Richard Bernstein stated that he has written to the Company’s chairman John Nicholas urging him to explore strategic alternatives for the Company. Richard Bernstein said that the Company was an attractive business currently valued by the stock market at substantially below its strategic value.
공고 • Apr 16Porvair plc Approves Final DividendPorvair plc at its AGM held on April 14, 2026, approved final dividend of 4.5 pence per ordinary share.
공고 • Feb 11Porvair plc Recommends Final Dividend, Payable on 8 June 2026The Directors of Porvair plc recommend the payment of a final dividend of 4.5 pence per share (2024: 4.2 pence per share) to be paid on 8 June 2026 to shareholders on the register on 1 May 2026; the ex-dividend date is 30 April 2026. This makes a total dividend for the year of6.7pence per share (2024: 6.3 pence per share).
공고 • Feb 10Porvair plc, Annual General Meeting, Apr 14, 2026Porvair plc, Annual General Meeting, Apr 14, 2026. Location: the offices of burson buchanan, rose court, 2 southwark bridge road, se1 9hs, london United Kingdom
공고 • Feb 09Porvair plc to Report First Half, 2026 Results on Jun 29, 2026Porvair plc announced that they will report first half, 2026 results on Jun 29, 2026
공고 • Dec 16Porvair plc Provides Earnings Guidance for the Year Ended 30 November 2025Porvair plc provided earnings guidance for the year ended 30 November 2025. For the period, the Group expects revenue growth to be around 1% (2% at constant currency), with both operating profit and margin ahead of the prior year.
공고 • Sep 27Porvair plc Announces Board ChangesPorvair plc announced that Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025. Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI). Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland. On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair. Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025. Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.
공고 • Jun 30Porvair plc Declares an Interim Dividend, Payable on 22 August 2025The Directors of Porvair plc have declared an interim dividend of 2.2 pence (2024: 2.1 pence) per share to be paid on 22 August 2025 to shareholders on the register at the close of business on 18 July 2025; the ex-dividend date is 17 July 2025.
공고 • Jun 20Porvair plc to Report Fiscal Year 2025 Results on Feb 09, 2026Porvair plc announced that they will report fiscal year 2025 results on Feb 09, 2026
공고 • Apr 17Porvair plc Announces Change of Remuneration Committee Chair, Effective April 15, 2025Porvair plc announced that Sheena Mackay has succeeded Sally Martin as Chair of the Remuneration Committee with effect from 15 April 2025. Sally will continue to be the Senior Independent Director and a member of the Remuneration Committee, Nomination Committee and Audit Committee. Sally retains her responsibilities as the designated Director responsible for Employee Engagement. Sheena joined the Board on 28 October 2024 as a Non-Executive Director and has been a member of the Remuneration Committee, Nomination Committee and Audit Committee since her appointment. Sheena is also a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee.
공고 • Feb 10Porvair plc to Report First Half, 2025 Results on Jun 30, 2025Porvair plc announced that they will report first half, 2025 results on Jun 30, 2025
공고 • Oct 28Porvair plc Announces Appointment of Sheena Mackay as an Independent Non-Executive Director and Joins Its Audit Committee, Remuneration Committee and Nomination CommitteePorvair plc announced the appointment of Sheena Mackay as an Independent Non-Executive Director of the Company with effect from 28 October 2024. Sheena is a Non-Executive Director of Lords Group Trading plc, an Aim listed building material distributor, where she is Chair of the Remuneration Committee and Nomination Committee and a member of the Audit Committee. Sheena was a Non-Executive Director at Foxtons Group plc, the London based estate agency, from 2017 to 2023. Sheena's executive career spans more than 30 years in human capital management. Sheena was Group Human Resources Director for Smiths Group plc, a FTSE 100 global industrial technology company, between 2016 and 2022. Prior to Smiths, Sheena was Group Human Resources Director at Aggreko plc, a global supplier of temporary power and temperature control equipment, BBA Aviation plc, a multinational aviation services company, and SSL International Group plc, a multinational manufacturer and supplier of healthcare products. Prior to SSL Sheena's early career was at the General Electric Company plc, a global FTSE 100 industrial conglomerate. On appointment, Sheena will join the Audit Committee, Remuneration Committee and Nomination Committee.
공고 • Sep 23+ 2 more updatesPorvair plc Announces Chief Executive Officer ChangesPorvair plc announce the appointment of Hooman Caman Javvi as Chief Executive Officer designate and Director of the Company. He is expected to join the Group on 6 January 2025 and assume the role of Chief Executive on the retirement of Ben Stocks following the Company's AGM on 15 April 2025. Hooman was, until recently, Group Chief Operating Officer and member of the Board of Hill & Smith plc, a FTSE 250 international provider of sustainable infrastructure products and services. Before joining Hill & Smith in 2022, Hooman spent 11 years in senior management roles at Hitachi Energy and the ABB Group. He has an Engineering and Management degree from Linkoping University in Sweden and an MBA from the Stockholm School of Economics.
공고 • Jul 01Porvair plc Declares Interim Dividend, Payable on 21 August 2024The Directors of Porvair plc have declared an interim dividend of 2.1 pence (2023: 2.0 pence) per share to be paid on 21 August 2024 to shareholders on the register at the close of business on 19 July 2024; the ex-dividend date is 18 July 2024.
공고 • May 25Porvair plc to Report Fiscal Year 2024 Results on Feb 10, 2025Porvair plc announced that they will report fiscal year 2024 results on Feb 10, 2025
공고 • Apr 03Porvair plc Announces Resignation of Sarah Vawda as DirectorPorvair plc announces that Sarah Vawda resigned from the Board with immediate effect. a consequence of Sarah's resignation, AGM Resolution 10 "To elect Sarah Vawda as a Director" will be withdrawn from the resolutions to be put to the Company's AGM on 16 April 2024.
공고 • Feb 05+ 1 more updatePorvair plc to Report First Half, 2024 Results on Jul 01, 2024Porvair plc announced that they will report first half, 2024 results on Jul 01, 2024
공고 • Sep 07Porvair plc, Annual General Meeting, Apr 16, 2024Porvair plc, Annual General Meeting, Apr 16, 2024.
공고 • Jul 04Porvair plc Declares an Interim Dividend, Payable on 23 August 2023Porvair plc announced the Directors have declared an interim dividend of 2.0 pence (2022: 1.9 pence) per share to be paid on 23 August 2023 to shareholders on the register at the close of business on 21 July 2023; the ex-dividend date is 20 July 2023.
공고 • Jun 27Porvair plc Announces Appointment of Sarah Vawda as an Independent Non-Executive Director of the CompanyPorvair plc announced the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023. Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listedreputation management, marketing and communications,software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees ofNoveltech Private Feeds Ltd. (India),a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire. Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC. On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.
공고 • Jun 24Porvair plc to Report Fiscal Year 2023 Results on Jan 29, 2024Porvair plc announced that they will report fiscal year 2023 results on Jan 29, 2024
공고 • May 06Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc.Porvair plc (LSE:PRV) acquired Business and Assets of HRW Inc. on March 3, 2023.Porvair plc (LSE:PRV) completed the acquisition of Business and Assets of HRW Inc. on March 3, 2023.
공고 • May 05Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft.Porvair plc (LSE:PRV) agreed to acquire 100% stake in Ratiolab GmbH and Ratiolab Kft. on May 4, 2023. Regulatory approval is expected to take around three months. Ratiolab has annual external revenues of around €12 million. Sally Sha, Ralf Hoffman, Jürgen Wohlfart and John Kim of EC Mergers & Acquisitions acted as exclusive financial advisor to Ratiolab.
공고 • Jan 31Porvair plc to Report First Half, 2023 Results on Jul 03, 2023Porvair plc announced that they will report first half, 2023 results on Jul 03, 2023